Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. [electronic resource]
Producer: 20101027Description: 2112-21 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Antigens, CD34
- Benzamides
- Cells, Cultured
- Drug Resistance, Neoplasm
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Neoplastic Stem Cells -- drug effects
- Piperazines -- pharmacology
- Prognosis
- Pyrimidines -- pharmacology
- Stem Cells -- drug effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.